Gelteq is a Biotechnology company specialising in the development and deployment of gel-based oral delivery products. We offer a complete end-to-end service for the development of new products; and the conversion of existing products and formulations into gels. We also offer a highly versatile portfolio of pre-tested, and market-ready proprietary formulations that can be white-labelled or added to your existing product portfolio.
We have state-of-the-art laboratory facilities for R&D, formulation development and testing (GLP), and also the latest manufacturing processes for supply of material for up to - and including - non-clinical safety studies. We can further manage Phase I / II / III clinical studies batches and testing, or directly upscale production to market volume GMP manufacturing.
Our patented gel-based oral delivery system provides a unique alternative to existing delivery systems, extending your products’ reach and breathing a new lease of life into existing formulations and patents.
From feasibility, through to formulation, clinical research, and manufacturing – Gelteq will work with your team to ensure that each stage is clearly planned and smoothly executed.
Our gel platform has been deployed to patients and consumers around the world, ensuring market viability, . We continue to produce millions of gels, further showcasing this new innovation is the delivery method of the future.
Gelteq has multiple proprietary gel formulations and shelf ready product lines for pharmaceutical, pet and veterinary, nutritional, and sports performance applications.
This approach offers readily available and commercially viable products at a substantially lower cost - and in a fraction of the time it would take to create a new product.
If you are interested in white labelling an existing formulation, or distributing an existing line of product, please
contact us.